PRECLINICAL DEVELOPMENT OF A ROMIDEPSIN NANOPARTICLE DEMONSTRATES SUPERIOR TOLERABILITY AND EFFICACY IN MODELS OF HUMAN T-CELL LYMPHOMA AND LARGE GRANULAR LYMPHOCYTE LEUKEMIA
Ipsita Pal, Anuradha Illendula, Andrea Joyner, John Sanil Manavalan, Tess M. Deddens, Ariana Sabzevari, Deepthi Priyanka Damera, Samir Zuberi, Enrica Marchi, Todd E. Fox, Marya E. Dunlap-Brown, Kallesh Danappa Jayappa, Jihane Khalife, Jeffrey W. Craig, Thomas P. Loughran, , Owen A. O’Connor
Blood · Sep 2, 2025Peer-reviewedCancer Biology